These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27217031)

  • 1. Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.
    Frommeyer G; Dechering DG; Kochhäuser S; Bettin M; Köbe J; Eckardt L; Reinke F
    J Interv Card Electrophysiol; 2016 Nov; 47(2):185-188. PubMed ID: 27217031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.
    Frommeyer G; Dechering DG; Zumhagen S; Löher A; Köbe J; Eckardt L; Reinke F
    Clin Res Cardiol; 2016 Jan; 105(1):89-93. PubMed ID: 26233714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.
    Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C
    Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term single-center experience of defibrillator therapy in children and adolescents.
    Frommeyer G; Feder S; Bettin M; Debus V; Köbe J; Reinke F; Uebing A; Eckardt L; Kehl HG
    Int J Cardiol; 2018 Nov; 271():105-108. PubMed ID: 29885825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical experience of the safety and feasibility of total subcutaneous implantable defibrillator in an Asian population.
    Hai JJ; Lim ET; Chan CP; Chan YS; Chan KK; Chong D; Ho KL; Tan BY; Teo WS; Ching CK; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii63-8. PubMed ID: 26842117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Pain wave": P‑wave oversensing in subcutaneous ICD.
    Kattih B; Duncker D; König T; Hohmann S; Oswald H; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2016 Jun; 27(2):151-3. PubMed ID: 27084342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the entirely subcutaneous ICD in borderline indications.
    Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2020 Jun; 109(6):694-699. PubMed ID: 31586219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death　- Primary Japanese Experience.
    Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
    Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.
    Köbe J; Reinke F; Meyer C; Shin DI; Martens E; Kääb S; Löher A; Amler S; Lichtenberg A; Winter J; Eckardt L
    Heart Rhythm; 2013 Jan; 10(1):29-36. PubMed ID: 23032867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.
    Lambiase PD; Barr C; Theuns DA; Knops R; Neuzil P; Johansen JB; Hood M; Pedersen S; Kääb S; Murgatroyd F; Reeve HL; Carter N; Boersma L;
    Eur Heart J; 2014 Jul; 35(25):1657-65. PubMed ID: 24670710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease.
    Willy K; Bettin M; Reinke F; Bögeholz N; Ellermann C; Rath B; Leitz P; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2019 Nov; 108(11):1234-1239. PubMed ID: 30903274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.